Skip to content

Reported May 7, 2026 · After market close

Revenue estimate$74.1M
EPS estimate-$0.13

Next report

Aug 6, 2026 (in a month)
Revenue estimate$80.1M
EPS estimate$0.05

Financials

Q1 2026

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation & ratios

Valuation

as of 06/25/26
See full
Market cap$1.11B
P/S3.9×

Profitability

See full
Gross margin66.3%+4.4pp

Returns & leverage

See full
Current ratio3.9×

Segments

By product

See full
Services$69.6M+40.6%
Hardware$8.5M+54.6%

By segment

See full
Reportable Segment$78.0M+42.0%

Versus estimates

Ask the moment Omada Health, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Omada Health, Inc. Common Stock report Q1 2026 earnings?
Omada Health, Inc. Common Stock (OMDA) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Omada Health, Inc. Common Stock's Q1 2026 revenue and EPS?
Omada Health, Inc. Common Stock reported revenue of $78.0M and diluted EPS of $-0.05 for Q1 2026.
Did Omada Health, Inc. Common Stock beat estimates in Q1 2026?
Revenue beat the consensus estimate of $74.1M by $4.0M. EPS beat the consensus estimate of $-0.13 by $0.08.
Where can I find Omada Health, Inc. Common Stock's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-032063) and the 10-Q periodic report (0001628280-26-032875) directly on SEC EDGAR. The filing index links above go to sec.gov.